Angela Rossetti - 17 Apr 2026 Form 4/A - Amendment Insider Report for AETHLON MEDICAL INC (AEMD)

Reporting relationship: Director
Issuer ticker: AEMD
Reported as of: 17 Apr 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 15 Oct 2026, 12:49:46 UTC
Original report date: 21 Apr 2026
Prior SEC filing: 25 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Angela Rossetti by: James B. Frakes, Attorney-in-fact

Key filing fact

Angela Rossetti filed Form 4/A - Amendment for AETHLON MEDICAL INC (AEMD) on 15 Oct 2026.

Key facts

This page summarizes Angela Rossetti's Form 4/A - Amendment filing for AETHLON MEDICAL INC (AEMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Oct 2026, 12:49.

Change

Previous filing in this sequence was filed on 25 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001580657 Primary reporting owner

Rossetti Angela

Relationship: Director
Address: 11555 SORRENTO VALLEY ROAD, STE 203, SAN DIEGO
Signature: /s/ Angela Rossetti by: James B. Frakes, Attorney-in-fact
Signature date: 15 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AEMD transaction

Common Stock

Award

Transaction value
Shares: +21,815
Change %
Price: $2.29^*
Shares after: 4,846
Date: 17 Apr 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.

Footnote F2

The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 26,207 shares, but should have been 24,222. This number accounts for Aethlon's recent reverse stock split.